112 related articles for article (PubMed ID: 14659657)
1. Efficacy of human salivary mucin MUC7-derived peptide and histatin 5 in a murine model of candidiasis.
Intini G; Aguirre A; Bobek LA
Int J Antimicrob Agents; 2003 Dec; 22(6):594-600. PubMed ID: 14659657
[TBL] [Abstract][Full Text] [Related]
2. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.
Situ H; Bobek LA
Antimicrob Agents Chemother; 2000 Jun; 44(6):1485-93. PubMed ID: 10817697
[TBL] [Abstract][Full Text] [Related]
3. Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7.
Satyanarayana J; Situ H; Narasimhamurthy S; Bhayani N; Bobek LA; Levine MJ
J Pept Res; 2000 Nov; 56(5):275-82. PubMed ID: 11095181
[TBL] [Abstract][Full Text] [Related]
4. Human salivary MUC7 mucin peptides: effect of size, charge and cysteine residues on antifungal activity.
Situ H; Wei G; Smith CJ; Mashhoon S; Bobek LA
Biochem J; 2003 Oct; 375(Pt 1):175-82. PubMed ID: 12812519
[TBL] [Abstract][Full Text] [Related]
5. Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells.
Wei GX; Bobek LA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2336-42. PubMed ID: 15917530
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
7. MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action.
Bobek LA; Situ H
Antimicrob Agents Chemother; 2003 Feb; 47(2):643-52. PubMed ID: 12543672
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.
Liao H; Liu S; Wang H; Su H; Liu Z
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645176
[TBL] [Abstract][Full Text] [Related]
9. Proteomic and metabolic characterization of a Candida albicans mutant resistant to the antimicrobial peptide MUC7 12-mer.
Lis M; Bobek LA
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):80-91. PubMed ID: 18680518
[TBL] [Abstract][Full Text] [Related]
10. The recombinant N-terminal region of human salivary mucin MG2 (MUC7) contains a binding domain for oral Streptococci and exhibits candidacidal activity.
Liu B; Rayment SA; Gyurko C; Oppenheim FG; Offner GD; Troxler RF
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):557-64. PubMed ID: 10642514
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity.
Ramalingam K; Gururaja TL; Ramasubbu N; Levine MJ
Biochem Biophys Res Commun; 1996 Aug; 225(1):47-53. PubMed ID: 8769093
[TBL] [Abstract][Full Text] [Related]
12. Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1.
Gururaja TL; Levine JH; Tran DT; Naganagowda GA; Ramalingam K; Ramasubbu N; Levine MJ
Biochim Biophys Acta; 1999 Apr; 1431(1):107-19. PubMed ID: 10209284
[TBL] [Abstract][Full Text] [Related]
13. Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.
Rothstein DM; Spacciapoli P; Tran LT; Xu T; Roberts FD; Dalla Serra M; Buxton DK; Oppenheim FG; Friden P
Antimicrob Agents Chemother; 2001 May; 45(5):1367-73. PubMed ID: 11302797
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide.
Wei GX; Campagna AN; Bobek LA
Ann Clin Microbiol Antimicrob; 2007 Nov; 6():14. PubMed ID: 17996119
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Chemistry, Structure, and Biological Activity of Human Salivary MUC7 Fragments and Their Cu(II) and Zn(II) Complexes.
Szarszoń K; Andrä S; Janek T; Wątły J
Inorg Chem; 2024 Jun; 63(25):11616-11627. PubMed ID: 38856909
[TBL] [Abstract][Full Text] [Related]
16. Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation.
Helmerhorst EJ; van't Hof W; Breeuwer P; Veerman EC; Abee T; Troxler RF; Amerongen AV; Oppenheim FG
J Biol Chem; 2001 Feb; 276(8):5643-9. PubMed ID: 11099499
[TBL] [Abstract][Full Text] [Related]
17. Surface-modified poly(methyl methacrylate) enhances adsorption and retains anticandidal activities of salivary histatin 5.
Edgerton M; Raj PA; Levine MJ
J Biomed Mater Res; 1995 Oct; 29(10):1277-86. PubMed ID: 8557730
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
[TBL] [Abstract][Full Text] [Related]
19. Metal-binding and nuclease activity of an antimicrobial peptide analogue of the salivary histatin 5.
Melino S; Gallo M; Trotta E; Mondello F; Paci M; Petruzzelli R
Biochemistry; 2006 Dec; 45(51):15373-83. PubMed ID: 17176059
[TBL] [Abstract][Full Text] [Related]
20. Human salivary histatins: promising anti-fungal therapeutic agents.
Tsai H; Bobek LA
Crit Rev Oral Biol Med; 1998; 9(4):480-97. PubMed ID: 9825223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
